COMP <GO>
COR vs CAH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Cencora Inc. (NYSE) VS. Cardinal Health Inc. (NYSE) • 15-METRIC TALLY: COR 5
— CAH 8
■ METRIC PARITY
LAST: $330.84 (+0.09%) • MKT CAP: $63.07B
options-implied-move
—
LAST: $250.48 (-0.24%) • MKT CAP: $58.14B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COR VS. CAH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COR | CAH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.60% | 3.70% | -0.10 | CAH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 26.80% | 29.70% | -2.90 | CAH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.6x | 24.5x | -2.90 | COR | /valuation <GO> |
| Free Cash Flow Yield | 5.08% | 3.18% | +1.90 | COR | /fcf-yield <GO> |
| Operating Margin | 0.80% | 1.00% | -0.20 | CAH | /operating-margins <GO> |
| Net Profit Margin | 0.50% | 0.70% | -0.20 | CAH | /net-margins <GO> |
| Revenue Growth (YoY) | 9.30% | -1.90% | +11.20 | COR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.69% | 0.85% | -0.16 | CAH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.27 | 5.16 | +0.11 | COR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.8 | 59.1 | -5.30 | CAH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.90 | -0.02 | CAH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 37.8x | 34.6x | +3.20 | CAH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $63.07B | $58.14B | $4.93B | COR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COR REV | CAH REV | COR GROSS % | CAH GROSS % | COR FCF | CAH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $321.33B | $222.58B | 3.6% | 3.7% | $3.21B | $1.85B |
| FY 2024 | $293.96B | $226.83B | 3.4% | 3.3% | $3.00B | $3.25B |
| FY 2023 | $262.17B | $204.98B | — | — | -$7.89B | -$6.38B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COR // BETA 0.88
CAH // BETA 0.90